A detailed history of Icapital Wealth LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Icapital Wealth LLC holds 591 shares of VRTX stock, worth $296,947. This represents 0.16% of its overall portfolio holdings.

Number of Shares
591
Previous 591 -0.0%
Holding current value
$296,947
Previous $277,000 1.08%
% of portfolio
0.16%
Previous 0.15%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 24, 2023

SELL
$338.18 - $362.46 $14,541 - $15,585
-43 Reduced 6.78%
591 $205,000
Q2 2023

Aug 01, 2023

BUY
$314.42 - $351.91 $199,342 - $223,110
634 New
634 $223,000
Q2 2022

Aug 11, 2022

SELL
$234.96 - $292.55 $138,861 - $172,897
-591 Closed
0 $0
Q1 2022

Apr 12, 2022

BUY
$221.42 - $260.97 $130,859 - $154,233
591 New
591 $154,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Icapital Wealth LLC Portfolio

Follow Icapital Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Icapital Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Icapital Wealth LLC with notifications on news.